dark side of semaglutide A potentially blinding condition is a very rare effect the GLP-1 receptor agonist (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no Ozempic and GLP-1 Drugs: Risk

Yes, when paired with healthy lifestyle habits

Recomandarea exclude femeile nsrcinate

Managing side effects and building sustainable habits is key

This multifaceted approach makes Semaglutide a compelling option for individuals struggling with obesity, offering not only glycemic control but also significant reductions in body weight

Administered as a once-weekly subcutaneous injection, Ozempic is typically prescribed alongside diet and exercise modifications to improve glycaemic control in adults with type 2 diabetes

Specific genetic variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), FTO gene (rs9939609), and MC4R gene (rs17782313) can determine whether semaglutide effectively suppresses your appetite and optimizes energy balance